CstF-77 inhibitors constitute a distinct chemical class renowned for their pivotal role in modulating gene expression through the targeted inhibition of the CstF-77 protein. CstF-77, an essential component of the mRNA 3' end processing machinery, is integral for polyadenylation-a critical step in mRNA maturation. The inhibitors, designed to impede the function of CstF-77, are characterized by their ability to selectively bind to the protein and disrupt its interactions with other components of the mRNA processing complex. This disruption leads to alterations in the polyadenylation process, influencing the length of the poly(A) tail and ultimately impacting mRNA stability and translation efficiency.
CstF-77 inhibitors often exhibit a high degree of specificity for their target, employing various molecular motifs to interact with key binding sites on the protein. Some inhibitors leverage small organic molecules, while others may comprise peptidic or nucleotide-based entities. The development of these inhibitors is rooted in a comprehensive understanding of the structural and functional aspects of CstF-77, allowing for rational design strategies to enhance binding affinity and selectivity. The biochemical intricacies of CstF-77 inhibition have become an intriguing focus of research, shedding light on the dynamic interplay within the mRNA processing cascade. As researchers continue to delve into the nuances of this chemical class, the uncovering novel insights into gene expression regulation and cellular processes remains a compelling avenue of exploration in the realm of molecular biology.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D interferes with transcription by binding to DNA, which can indirectly influence mRNA processing. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
α-Amanitin inhibits RNA polymerase II, potentially affecting the transcription process that precedes mRNA maturation. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $43.00 $189.00 $316.00 $663.00 | 6 | |
DRB inhibits the activity of positive transcription elongation factor b (P-TEFb), which can indirectly influence pre-mRNA processing. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Triptolide inhibits the activity of XPB, a subunit of the transcription factor TFIIH, thereby potentially affecting mRNA processing. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Camptothecin inhibits DNA topoisomerase I, affecting DNA replication and transcription, which can indirectly influence mRNA processing. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Etoposide inhibits DNA topoisomerase II, which can affect DNA replication and transcription, thereby potentially influencing mRNA processing. | ||||||
Flavopiridol Hydrochloride | 131740-09-5 | sc-207687 | 10 mg | $317.00 | ||
Flavopiridol inhibits cyclin-dependent kinases, which can indirectly affect transcription and mRNA processing. | ||||||
Mycophenolic acid | 24280-93-1 | sc-200110 sc-200110A | 100 mg 500 mg | $69.00 $266.00 | 8 | |
Mycophenolic acid inhibits inosine monophosphate dehydrogenase, potentially influencing RNA synthesis and indirectly affecting mRNA processing. | ||||||
Ellipticine | 519-23-3 | sc-200878 sc-200878A | 10 mg 50 mg | $145.00 $569.00 | 4 | |
Ellipticine intercalates into DNA and inhibits topoisomerase II, which can indirectly affect transcription and mRNA processing. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Mithramycin A binds to DNA and inhibits RNA synthesis, which can indirectly influence mRNA processing. | ||||||